Myosin7a deficiency results in reduced retinal activity which is improved by gene therapy.
about
Specialized Cilia in Mammalian Sensory SystemsThe population genomics of rhesus macaques (Macaca mulatta) based on whole-genome sequencesUsher syndrome: Hearing loss, retinal degeneration and associated abnormalities.myosin 7aa(-/-) mutant zebrafish show mild photoreceptor degeneration and reduced electroretinographic responses.Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture.Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease.Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapy.EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7ADual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A.Gene therapies for inherited retinal disorders.Gene and cell-based therapies for inherited retinal disorders: An update.Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors.Emerging Issues in AAV-Mediated In Vivo Gene Therapy.Triple Vectors Expand AAV Transfer Capacity in the Retina.Cone degeneration is triggered by the absence of USH1 proteins but prevented by antioxidant treatments.Gene therapy and genome surgery in the retina.Severe retinal degeneration at an early age in Usher syndrome type 1B associated with homozygous splice site mutations in MYO7A gene.
P2860
Q26785912-8F78CB1F-B527-45E1-A728-8A80E8068640Q28591103-4B6FDF1C-D23A-4201-AFB2-FDAD08DA90D7Q30389509-256C7598-D874-43DE-9812-F26F3A120AECQ30413024-F1D505C1-9DD3-4EA7-8130-A853D452C917Q34090518-86B1A5C2-3D0C-4022-8721-9D21842E673AQ34497784-7F13568A-4067-4D35-A083-E05CC82E30D2Q35132187-32F560C9-AAC4-4DDB-A438-17635755DF48Q35140281-53D0074D-49AB-446A-8D35-1840350B9C4CQ35664199-14529973-A32A-494E-8CFF-B4BF97F4BDE6Q37710671-D8FB2940-93A7-4F2E-84E2-8F59153B12F0Q38221905-C5448B78-32D2-4CCC-A1F5-F6F6400B813DQ39013159-FDCF62AC-65BC-4F42-B28C-28B3A9475F92Q42235082-00060BFF-659B-4635-9F87-5D1FA5BFE069Q47554736-EADEA2AA-C9AE-49FD-A421-9B7EF42AD497Q47559127-DA93B9F0-8861-4C18-A79B-2FD89BB25925Q49196891-C0462AB7-51F7-42E7-957B-4A272E571A4CQ54977409-F7EEB6F5-3FB8-4D3C-A7DD-D8DF5014D1A9Q55334362-62579951-3584-4D51-BDA9-A476DB89F7DB
P2860
Myosin7a deficiency results in reduced retinal activity which is improved by gene therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Myosin7a deficiency results in ...... h is improved by gene therapy.
@ast
Myosin7a deficiency results in ...... h is improved by gene therapy.
@en
type
label
Myosin7a deficiency results in ...... h is improved by gene therapy.
@ast
Myosin7a deficiency results in ...... h is improved by gene therapy.
@en
prefLabel
Myosin7a deficiency results in ...... h is improved by gene therapy.
@ast
Myosin7a deficiency results in ...... h is improved by gene therapy.
@en
P2093
P2860
P1433
P1476
Myosin7a deficiency results in ...... h is improved by gene therapy.
@en
P2093
Andrea Sommella
Elena Marrocco
Elena Polishchuk
Marina Garcia Garrido
Mathias W Seeliger
Roman Polishchuk
Umberto Di Vicino
P2860
P304
P356
10.1371/JOURNAL.PONE.0072027
P407
P577
2013-08-26T00:00:00Z